[Monitoring of antiparkinson treatment].
D000855:Anorexia / Q000139:chemically induced; D000978:Antiparkinson Agents / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D006801:Humans; D009069:Movement Disorders / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents
Surveillance du traitement antiparkinsonien.